Skip to content
The Intraday Markets
Pulse

Briefings

Morning BriefOvernight tape and the setup for the openMid-Morning UpdateWhat changed after the opening bell

Markets

Market DashboardTape, movers, watchlist, and cross-asset contextPre-Market SheetOvernight setup, futures, and early moversGlobal SessionsInternational clocks and index performanceInsider ActivityLatest reported executive transactions

THC Research

Price ChartTechnical charting and drawing workspaceFundamentals ChartCompare financial metrics across timeCompany OverviewA visual snapshot of company performanceFinancial StatementsPrice, filings, key statistics, and news

Newsletter

Morning Production ReportRanked stories, charts, and newsletter readiness

Financial Statements

Explore

Markets, briefings, and company research

THC
Pulse

Briefings

MorningMid-Morning

Markets

DashboardPre-MarketGlobalInsiders

THC Research

ChartFundamentalsOverviewFinancials

Newsletter

Morning Report

Newsletter operations and account tools are available from your profile menu after sign-in.

THC

$267.90
+$0.85 (0.32%)+0.32%
After Hours
Loading chart...
IndexN/A
Market Cap21.57B
Enterprise Value28.20B
Income$0.41B
Sales$5.22B
EmployeesN/A
P/E15.54
P/S0.84
P/B4.25
P/C7.08
EV/EBITDA6.29
EV/SalesN/A
EPS (ttm)17.24
EarningsN/A
Gross Margin82.26%
Oper. Margin16.14%
Profit Margin6.60%
Volume0.30M
Shs Outstand0.08B
Change0.34%
Dividend Est.N/A
Dividend Ex-DateN/A
Perf YTDN/A
Perf YearN/A
Perf 3YN/A
Perf 5YN/A
Perf 10YN/A
IPON/A
Income Statement by fiscal year, newest to oldest
MetricFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Revenue$20.66B$20.55B$19.17B$19.48B$17.64B$18.48B$18.31B$19.18B
Cost of Revenue$12.46B$12.74B$12.13B$12.22B$11.41B$11.77B$11.65B$12.38B
Gross Profit$8.21B$7.80B$7.05B$7.27B$6.23B$6.71B$6.66B$6.79B
Gross Margin39.72%37.98%36.76%37.30%35.32%36.33%36.37%35.42%
Operating Expenses$2.25B$5.29B$4.71B$4.40B$4.24B$5.18B$5.02B$5.68B
Operating Income$5.96B$2.51B$2.33B$2.87B$1.99B$1.54B$1.64B$1.11B
Operating Margin28.82%12.22%12.17%14.73%11.28%8.32%8.94%5.80%
Net Income$3.20B$611.00M$411.00M$914.00M$399.00M$-215.00M$104.00M$-704.00M
Net Margin15.49%2.97%2.14%4.69%2.26%-1.16%0.57%-3.67%
EPS (Basic)$33.02$6.01$3.84$8.55$3.80$-2.24$1.09$-7.00
EBITDAN/AN/AN/AN/AN/AN/AN/AN/A
Stock Option Compensation ExpenseN/AN/AN/AN/AN/AN/AN/AN/A
Price To Earnings RatioN/AN/AN/AN/AN/AN/AN/AN/A
Price To Sales RatioN/AN/AN/AN/AN/AN/AN/AN/A
Shares OutstandingN/AN/AN/AN/AN/AN/AN/AN/A
Market CapitalizationN/AN/AN/AN/AN/AN/AN/AN/A
Balance Sheet by fiscal year, newest to oldest
MetricFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Cash & Short Term InvestmentsN/AN/AN/AN/AN/AN/AN/AN/A
Short Term ReceivablesN/AN/AN/AN/AN/AN/AN/AN/A
InventoriesN/AN/AN/AN/AN/AN/AN/AN/A
Other Current AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Total Current AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Net Property, Plant & EquipmentN/AN/AN/AN/AN/AN/AN/AN/A
Total Investments and AdvancesN/AN/AN/AN/AN/AN/AN/AN/A
Long-Term Note ReceivableN/AN/AN/AN/AN/AN/AN/AN/A
Intangible AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Deferred Tax AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Other AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Total Assets$28.94B$28.31B$27.16B$27.58B$27.11B$23.35B$22.41B$23.39B
Short Term Debt Incl. Current Port. of LT DebtN/AN/AN/AN/AN/AN/AN/AN/A
Accounts PayableN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax PayableN/AN/AN/AN/AN/AN/AN/AN/A
Other Current LiabilitiesN/AN/AN/AN/AN/AN/AN/AN/A
Total Current LiabilitiesN/AN/AN/AN/AN/AN/AN/AN/A
Long Term DebtN/AN/AN/AN/AN/AN/AN/AN/A
Provision for Risks ChargesN/AN/AN/AN/AN/AN/AN/AN/A
Deferred Tax LiabilitiesN/AN/AN/AN/AN/AN/AN/AN/A
Other LiabilitiesN/AN/AN/AN/AN/AN/AN/AN/A
Total Liabilities$20.39B$22.80B$22.55B$23.32B$24.22B$21.36B$20.30B$20.98B
Non-Equity ReservesN/AN/AN/AN/AN/AN/AN/AN/A
Preferred Stock - Carrying ValueN/AN/AN/AN/AN/AN/AN/AN/A
Common EquityN/AN/AN/AN/AN/AN/AN/AN/A
Total Shareholders Equity$4.17B$1.61B$1.14B$1.03B$28.00M$-371.00M$-119.00M$-147.00M
Accumulated Minority InterestN/AN/AN/AN/AN/AN/AN/AN/A
Total Equity$4.17B$1.61B$1.14B$1.03B$28.00M$-371.00M$-119.00M$-147.00M
Total Liabilities & Stockholders Equity$28.94B$28.31B$27.16B$27.58B$27.11B$23.35B$22.41B$23.39B
Book Value Per ShareN/AN/AN/AN/AN/AN/AN/AN/A
Tangible Book Value Per ShareN/AN/AN/AN/AN/AN/AN/AN/A
Full-Time EmployeesN/AN/AN/AN/AN/AN/AN/AN/A
Price to Book RatioN/AN/AN/AN/AN/AN/AN/AN/A
Return on AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Return on EquityN/AN/AN/AN/AN/AN/AN/AN/A
Return on Invested CapitalN/AN/AN/AN/AN/AN/AN/AN/A
Quick RatioN/AN/AN/AN/AN/AN/AN/AN/A
Current RatioN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow by fiscal year, newest to oldest
MetricFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Net Income$3.20B$611.00M$411.00M$914.00M$399.00M$-215.00M$104.00M$-704.00M
DepreciationN/AN/AN/AN/AN/AN/AN/AN/A
Other Funds (Non Cash)N/AN/AN/AN/AN/AN/AN/AN/A
Funds from OperationsN/AN/AN/AN/AN/AN/AN/AN/A
Extraordinary ItemN/AN/AN/AN/AN/AN/AN/AN/A
Changes in Working CapitalN/AN/AN/AN/AN/AN/AN/AN/A
Income Taxes PayableN/AN/AN/AN/AN/AN/AN/AN/A
Cash from Operating Activities$2.05B$2.37B$1.08B$1.57B$3.41B$1.23B$1.05B$1.20B
Capital ExpendituresN/AN/AN/AN/AN/AN/AN/AN/A
Net Assets From AcquisitionsN/AN/AN/AN/AN/AN/AN/AN/A
Sale of Fixed Assets and BusinessesN/AN/AN/AN/AN/AN/AN/AN/A
Purchase or Sale of InvestmentsN/AN/AN/AN/AN/AN/AN/AN/A
Purchase of InvestmentsN/AN/AN/AN/AN/AN/AN/AN/A
Sale Or Maturity of InvestmentsN/AN/AN/AN/AN/AN/AN/AN/A
Other UsesN/AN/AN/AN/AN/AN/AN/AN/A
Other SourcesN/AN/AN/AN/AN/AN/AN/AN/A
Cash from Investing ActivitiesN/AN/AN/AN/AN/AN/AN/AN/A
Cash Dividends PaidN/AN/AN/AN/AN/AN/AN/AN/A
Change in Capital StockN/AN/AN/AN/AN/AN/AN/AN/A
Repurchase of Common Pref StockN/AN/AN/AN/AN/AN/AN/AN/A
Sale of Common Pref StockN/AN/AN/AN/AN/AN/AN/AN/A
Proceeds from Stock OptionsN/AN/AN/AN/AN/AN/AN/AN/A
Issuance or Reduction of Debt, NetN/AN/AN/AN/AN/AN/AN/AN/A
Change in Long Term DebtN/AN/AN/AN/AN/AN/AN/AN/A
Issuance of Long Term DebtN/AN/AN/AN/AN/AN/AN/AN/A
Reduction of Long Term DebtN/AN/AN/AN/AN/AN/AN/AN/A
Net Financing Active Other Cash FlowN/AN/AN/AN/AN/AN/AN/AN/A
Other Financing Activities UsesN/AN/AN/AN/AN/AN/AN/AN/A
Cash from Financing ActivitiesN/AN/AN/AN/AN/AN/AN/AN/A
Exchange Rate EffectN/AN/AN/AN/AN/AN/AN/AN/A
Net Change in CashN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash FlowN/AN/AN/AN/AN/AN/AN/AN/A
Preferred Dividends (Cash Flow)N/AN/AN/AN/AN/AN/AN/AN/A
Price to Free Cash FlowN/AN/AN/AN/AN/AN/AN/AN/A

Company coverage

Latest news

20 stories
May 24 · 1:26PMNIO, Intuit, And Reddit Are Among Top 10 Large-Cap Losers Last Week (May 18-May 22): Are The Others In Your Portfolio?Benzinga ↗Apr 30 · 6:33PMTenet Healthcare Blames Admissions Mix For Soft Q1 SalesBenzinga ↗Feb 11 · 5:34PMTenet Healthcare Quarterly Profit Surges As Hospital, Surgery Demand GrowsBenzinga ↗Nov 18 · 7:27AMWhy Tenet Healthcare Could Be the Sector’s Big WinnerInvesting.com ↗Jul 22 · 9:28PMTenet Revenue Tops Estimates in Q2The Motley Fool ↗May 4 · 1:52PMDuolingo, CoreWeave And DexCom Are Among Top 10 Large-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?Benzinga ↗Mar 19 · 8:32AMPlastic Fencing Market to be Driven by Growing Residential and Commercial Construction Activities, Exclusive Research by The Insight PartnersGlobeNewswire Inc. ↗Jan 31 · 2:00PMTenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech ConferenceGlobeNewswire Inc. ↗
Show 12 more stories↓
Jan 28 · 10:19PMTrump's Federal Spending Freeze Puts $3 Trillion In Limbo, Threatens Industries Like Clean Energy, Defense, Health CareBenzinga ↗Jan 14 · 6:00PMEvolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsightGlobeNewswire Inc. ↗Nov 22 · 9:39AMBehavioral Rehabilitation Market to Witness 6.9% CAGR by 2031 | SkyQuest TechnologyGlobeNewswire Inc. ↗Sep 5 · 4:39PMEnsign Adds 8 Facilities in Kansas & Colorado to Expand FootprintBenzinga ↗Aug 20 · 12:57PMEurope Pavement Reinforcement Materials (Carbon Fiber, Glass Fiber, Steel Rebar) Industry Analysis Report 2024-2030GlobeNewswire Inc. ↗Aug 2 · 12:43PMZacks.com featured highlights Universal Health Services, Tenet Healthcare Corp., Century Communities and MagniteZacks Investment Research ↗Jul 31 · 8:18AMZacks.com featured highlights Hilton Grand Vacations, Tenet Healthcare, Universal Health, Popular and B2GoldZacks Investment Research ↗Jul 19 · 3:19PM4 Healthcare Stocks Poised to Beat Q2 Earnings Estimates - Zacks Investment ResearchZacks Investment Research ↗Jul 2 · 6:01PMTenet Healthcare Stock: A Deep Dive Into Analyst Perspectives (13 Ratings)Benzinga ↗Jul 2 · 3:03PM4 Stocks That Boast Remarkable Interest Coverage RatioZacks Investment Research ↗Jun 28 · 2:58PMCommunity Health (CYH) & Cost Plus Drugs Expand CollaborationZacks Investment Research ↗Jun 28 · 12:32PM4 Stocks Trading Near 52-Week High That Can Climb FurtherZacks Investment Research ↗

Insider Trading

View All
Insider
Type
Shares
Price
Value
Date
Romo Tammy
Sell
2.5K
$260.83
$652K
Aug 7, 26
Romo Tammy
Sell
2.5K
$260.82
$652K
Aug 7, 26
Romo Tammy
Sell
4.9K
$264.15
$1.3M
Aug 6, 26
Romo Tammy
Sell
4.9K
$264.15
$1.3M
Aug 6, 26
Blunt Roy
Sell
600
$262.68
$158K
Aug 5, 26

Company

CEO: Saumya SutariaEmployees: 88500www.tenethealth.com
About the company↓

Tenet Healthcare Corporation operates as a broad-ranging provider of health solutions. The company organizes its operations across three main divisions: Hospital Operations and Other, Ambulatory Care, and Conifer. Within its network of acute care facilities, Tenet delivers a full spectrum of essential services. These include core hospital functions such as operating and recovery suites, radiology and respiratory therapy, clinical laboratories, and on-site pharmacies. The organization also provides high-acuity patient care through intensive, critical, and coronary care units. Specialized medical services cover areas like cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics, alongside various outpatient treatments, including physical therapy. Advanced surgical capabilities feature cardiothoracic, complex spinal, and neurosurgery, as well as neonatal intensive care. Tenet extends its offerings to ultra-specialized quaternary care, exemplified by heart and kidney transplant programs, and sophisticated procedures such as limb-salvaging vascular interventions, acute Level 1 trauma care, intravascular stroke treatment, minimally invasive cardiac valve replacements, advanced imaging, and telemedicine access. Beyond its hospital network, Tenet manages numerous other clinical sites. These encompass outpatient surgical centers, immediate care facilities, diagnostic imaging centers, dedicated surgical hospitals, off-campus emergency departments, and micro-hospitals. Through its Conifer segment, the company furnishes critical healthcare business process solutions. These administrative services, offered to hospitals, health systems, physician practices, employers, and other clients, include financial administration for patient accounts (revenue cycle management), support for patient communications and engagement, and outcome-focused care strategies. As of February 9, 2022, Tenet's operational footprint included 60 hospitals and roughly 550 additional medical facilities. This count of additional sites comprises surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and various other clinical locations. Tenet Healthcare Corporation was established in 1975 and maintains its principal office in Dallas, Texas.

Discover more

You may be interested in
ADBE

Adobe Inc

$264.02

↓ 2.39%
IBM

IBM Corp

$234.32

↓ 1.19%
JPM

JPMorgan Chase & Co

$362.84

↓ 0.07%
GOOGL

Alphabet Inc

$345.90

↓ 0.13%
TSLA

Tesla Inc

$342.27

↑ 0.64%
NVDA

NVIDIA Corp

$225.16

↓ 0.15%
INTC

Intel Corp

$102.50

↓ 1.92%
BAC

Bank of America Corp

$64.49

↑ 0.62%
AMD

Advanced Micro Devices

$514.39

↑ 6.50%
CRM

Salesforce Inc

$196.21

↓ 2.56%
PYPL

PayPal Holdings Inc

$61.66

↑ 1.50%
MA

Mastercard Inc

$569.29

↑ 0.40%
The Intraday Markets

© 2026 The Intraday. All rights reserved.

Market data may be delayedFor informational purposes onlyFMP · Massive · SEC